Comment on "efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke"
10.1016/j.jocn.2010.07.104
Saved in:
Main Authors: | Ahmad, A., Sharma, V.K. |
---|---|
Other Authors: | MEDICINE |
Format: | Others |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/125753 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in acute ischemic stroke
by: Loh, P.K., et al.
Published: (2016) -
Low-dose versus standard-dose tissue plasminogen activator for intravenous thrombolysis in asian acute ischemic stroke patients
by: Ng, K.W.P., et al.
Published: (2016) -
Comment on "Intravenous thrombolysis for acute ischemic stroke: The Malabar experience 2003 to 2008"
by: Sharma, V.K., et al.
Published: (2016) -
Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: An updated systematic review
by: Wang X., et al.
Published: (2019) -
Intravenous thrombolysis for acute ischemic stroke in Asia
by: Sharma, V.K., et al.
Published: (2016)